-
Human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus env proteins possess a functionally conserved assembly domain.
J Virol. 1990 Jul;64(7):3537-40
PMID: 2352332
-
Characterization of recombinant gp120 and gp160 from HIV-1: binding to monoclonal antibodies and soluble CD4.
AIDS. 1990 Apr;4(4):307-15
PMID: 2190605
-
High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates.
Proc Natl Acad Sci U S A. 1990 Sep;87(17):6574-8
PMID: 2395859
-
The human immunodeficiency virus type 1 envelope glycoprotein precursor acquires aberrant intermolecular disulfide bonds that may prevent normal proteolytic processing.
Virology. 1990 Dec;179(2):827-33
PMID: 2238472
-
Dissociation of gp120 from HIV-1 virions induced by soluble CD4.
Science. 1990 Nov 23;250(4984):1139-42
PMID: 2251501
-
Morphometric analysis of recombinant soluble CD4-mediated release of the envelope glycoprotein gp120 from HIV-1.
AIDS Res Hum Retroviruses. 1990 Oct;6(10):1209-12
PMID: 2252640
-
Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization.
J Virol. 1991 Feb;65(2):852-60
PMID: 1898972
-
Enhancement of soluble CD4-mediated HIV neutralization and gp 120 binding by CD4 autoantibodies and monoclonal antibodies.
AIDS Res Hum Retroviruses. 1990 Nov;6(11):1273-9
PMID: 2078408
-
Differences in the interaction of HIV-1 and HIV-2 with CD4.
J Acquir Immune Defic Syndr. 1990;3(7):649-57
PMID: 1693676
-
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.
Nature. 1984 Dec 20-1985 Jan 2;312(5996):763-7
PMID: 6096719
-
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV.
Nature. 1984 Dec 20-1985 Jan 2;312(5996):767-8
PMID: 6083454
-
Loss of envelope antigens of HTLV-III/LAV, a factor in AIDS pathogenesis?
Lancet. 1985 Nov 2;2(8462):1016-7
PMID: 2865493
-
The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.
Cell. 1986 Nov 7;47(3):333-48
PMID: 3094962
-
Shedding and interspecies type sero-reactivity of the envelope glycopolypeptide gp120 of the human immunodeficiency virus.
J Gen Virol. 1986 Nov;67 ( Pt 11):2533-8
PMID: 2431105
-
Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor.
Cell. 1987 Sep 11;50(6):975-85
PMID: 2441877
-
Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen.
Science. 1987 Dec 18;238(4834):1704-7
PMID: 3500514
-
A soluble CD4 protein selectively inhibits HIV replication and syncytium formation.
Nature. 1988 Jan 7;331(6151):78-81
PMID: 2829023
-
A soluble form of CD4 (T4) protein inhibits AIDS virus infection.
Nature. 1988 Jan 7;331(6151):82-4
PMID: 3257544
-
Soluble CD4 molecules neutralize human immunodeficiency virus type 1.
Nature. 1988 Jan 7;331(6151):84-6
PMID: 2829024
-
The CD4 antigen: physiological ligand and HIV receptor.
Cell. 1988 Mar 11;52(5):631-3
PMID: 2830988
-
Neutralizing monoclonal antibodies to the AIDS virus.
AIDS. 1988 Feb;2(1):25-9
PMID: 2451922
-
The human and simian immunodeficiency viruses HIV-1, HIV-2 and SIV interact with similar epitopes on their cellular receptor, the CD4 molecule.
AIDS. 1988 Apr;2(2):101-5
PMID: 2454642
-
Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4.
J Virol. 1988 Nov;62(11):4195-200
PMID: 2845130
-
Characterization of GP120 binding to CD4 and an assay that measures ability of sera to inhibit this binding.
J Immunol. 1988 Dec 15;141(12):4181-6
PMID: 3264307
-
Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells.
Nature. 1989 Jan 26;337(6205):368-70
PMID: 2536142
-
An enzyme-linked immunosorbent assay for antibodies to the envelope glycoproteins of divergent strains of HIV-1.
AIDS. 1989 Mar;3(3):155-63
PMID: 2540772
-
Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules.
Nature. 1989 May 4;339(6219):68-70
PMID: 2541344
-
Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1.
J Virol. 1989 Jun;63(6):2674-9
PMID: 2786089
-
A general model for the transmembrane proteins of HIV and other retroviruses.
AIDS Res Hum Retroviruses. 1989 Aug;5(4):431-40
PMID: 2788443
-
Studies with crosslinking reagents on the oligomeric structure of the env glycoprotein of HIV.
Virology. 1989 Sep;172(1):367-9
PMID: 2672564
-
Characterization of in vitro inhibition of human immunodeficiency virus by purified recombinant CD4.
J Virol. 1989 Oct;63(10):4370-5
PMID: 2550671
-
Evaluation of human and simian immunodeficiency virus plaque and neutralization assays.
J Gen Virol. 1989 Dec;70 ( Pt 12):3327-33
PMID: 2575137
-
Recombinant soluble CD4 therapy in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase I-II escalating dosage trial.
Ann Intern Med. 1990 Feb 15;112(4):247-53
PMID: 2297203
-
The safety and pharmacokinetics of recombinant soluble CD4 (rCD4) in subjects with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase 1 study.
Ann Intern Med. 1990 Feb 15;112(4):254-61
PMID: 2297204
-
Biological properties of a CD4 immunoadhesin.
Nature. 1990 Apr 12;344(6267):667-70
PMID: 1970124
-
Simple methods for monitoring HIV-1 and HIV-2 gp120 binding to soluble CD4 by enzyme-linked immunosorbent assay: HIV-2 has a 25-fold lower affinity than HIV-1 for soluble CD4.
AIDS. 1990 Apr;4(4):297-305
PMID: 2190604
-
HIV requires multiple gp120 molecules for CD4-mediated infection.
Nature. 1990 Jul 19;346(6281):277-9
PMID: 2374593